EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Characterization of 35 Novel NR5A1 /SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study

Rawda Naamneh Elzenaty iD, Idoia Martinez de Lapiscina, Chrysanthi Kouri, Kay-Sara Sauter, Grit Sommer, Luis Castaño, Christa E Flück iD

The Journal of Clinical Endocrinology & Metabolism · 2025

DOI: 10.1210/clinem/dgae251 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Rawda Naamneh Elzenaty und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, …. Hauptthemen laut MEDLINE: Steroidogenic Factor 1, Disorders of Sex Development. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 75 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Swiss National Science Foundation, Education Department of Basque Government.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Context

Steroidogenic factor 1 (NR5A1/SF-1) is a nuclear receptor that regulates sex development, steroidogenesis, and reproduction. Genetic variants in NR5A1/SF-1 are common among differences of sex development (DSD) and associate with a wide range of phenotypes, but their pathogenic mechanisms remain unclear.

Objective

Novel, likely disease-causing NR5A1/SF-1 variants from the SF1next cohort of individuals with DSD were characterized to elucidate their pathogenic effect.

Methods

Different in silico tools were used to predict the impact of novel NR5A1/SF-1 variants on protein function. An extensive literature review was conducted to compare and select the best functional studies for testing the pathogenic effect of the variants in a classic cell culture model. The missense NR5A1/SF-1 variants were tested on the promoter luciferase reporter vector -152CYP11A1_pGL3 in HEK293T cells and assessed for their cytoplasmic/nuclear localization by Western blot.

Results

Thirty-five novel NR5A1/SF-1 variants were identified in the SF1next cohort. Seventeen missense NR5A1/SF-1 variants were functionally tested. Transactivation assays showed reduced activity for 40% of the variants located in the DNA binding domain and variable activity for variants located elsewhere. Translocation assessment revealed 3 variants (3/17) with affected nuclear translocation. No clear genotype-phenotype, structure-function correlation was found.

Conclusion

Genetic analyses and functional assays do not explain the observed wide phenotype of individuals with these novel NR5A1/SF-1 variants. In 9 individuals, additional likely disease-causing variants in other genes were found, strengthening the hypothesis that the broad phenotype of DSD associated with NR5A1/SF-1 variants may be caused by an oligogenic mechanism.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Steroidogenic Factor 1Disorders of Sex DevelopmentHumansMaleFemaleHEK293 CellsChildAdolescentMutation, MissenseAdultCohort StudiesChild, PreschoolPhenotypeGenetic VariationRNA Splicing Factors

Stichwörter der Autor:innen

broad phenotypedifferences of sex development (DSD)genotype-phenotype correlationsteroidogenic factor 1 (SF-1/NR5A1)

Substanzen

Steroidogenic Factor 1NR5A1 protein, humanSF1 protein, humanRNA Splicing Factors

Autor:innen und Institutionen

  • Pediatric Endocrinology, Diabetology and Metabolism, Department of Pediatrics, Inselspital, Bern University Hospital, University of Bern, 3010 Bern, Switzerland.
  • Department of BioMedical Research, University of Bern, 3008 Bern, Switzerland.
  • Graduate School for Cellular and Biomedical Sciences, University of Bern, 3012 Bern, Switzerland.
  • Research into the Genetics and Control of Diabetes and other Endocrine Disorders, Biobizkaia Health Research Institute, Cruces University Hospital, 48903 Barakaldo, Spain.
  • CIBER de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Instituto de Salud Carlos III, 28029 Madrid, Spain.
  • CIBER de Enfermedades Raras (CIBERER), Instituto de Salud Carlos III, 28029 Madrid, Spain.

ORCID-Profile: Rawda Naamneh Elzenaty, Christa E Flück

Förderung

  • Swiss National Science Foundation
  • Education Department of Basque Government

Zitieren

APA

Naamneh Elzenaty, R., Martinez de Lapiscina, I., Kouri, C., Sauter, K. S., Sommer, G., Castaño, L., & Flück, C. E. (2025). Characterization of 35 Novel NR5A1 /SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae251

Vancouver

Naamneh Elzenaty R, Martinez de Lapiscina I, Kouri C, Sauter KS, Sommer G, Castaño L, et al. Characterization of 35 Novel NR5A1 /SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae251

BibTeX
@article{NaamnehElzenaty2025,
  author = {Naamneh Elzenaty, Rawda and Martinez de Lapiscina, Idoia and Kouri, Chrysanthi and Sauter, Kay-Sara and Sommer, Grit and Castaño, Luis and Flück, Christa E},
  title = {Characterization of 35 Novel NR5A1 /SF-1 Variants Identified in Individuals With Atypical Sexual Development: The SF1next Study},
  journal = {The Journal of Clinical Endocrinology & Metabolism},
  year = {2025},
  doi = {10.1210/clinem/dgae251}
}
Kostenlos starten →